Advertisement

Topics

Sanpower Group Closes Acquisition of Dendreon

07:21 EDT 29 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
– Company to Focus on Accelerating Its Positive Growth Trajectory for PROVENGE and Expanding Clinical Development Program – – James Caggiano Promoted to Chief Executive Officer of Dendreon – Dendreon Pharmac...

Other Sources for this Article

For Dendreon Pharmaceuticals LLC
Leslie Bryant, +1 562-505-9290
lbryant@w2ogroup.com
or
Sanpower Group
Jeffrey Jing
jingtian@sanpowergroup.com
or
Jason Ji
jiliang@sanpowergroup.com

NEXT ARTICLE

More From BioPortfolio on "Sanpower Group Closes Acquisition of Dendreon"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Searches Linking to this Story